IOF Anti-Doping Report 2016

Posted on | December 12, 2016 | Category: News, Newsletter

During 2016, a total of 102 In-Competition Doping Controls were performed by the IOF. The tests were spread over 10 different IOF Major Events in SkiO, FootO, MTBO and TrailO. A total of 84 individual athletes were tested, representing 22 different Nationalities.

All but one of these tests produced a negative result. This one test produced an Adverse Analytical Finding for a substance which was covered by a Therapeutic Use Exemption granted to the athlete in question by the IOF Medical Commission, and is therefore not regarded as an Anti-Doping Rule Violation.

The IOF has also increased its Out-of-Competition testing programme. So far in 2016, 22 Out-of-Competition Doping Controls have been done by the IOF, representing an 83% increase from 2015. All results of these tests have been negative. The IOF has also introduced the use of the Haematological Module of the Athlete Biological Passport. This work has involved increased cooperation with National Anti-Doping Organisations and the Nordic Athlete Passport Management Unit.

ad-stats
* World Anti-Doping Agency’s Minimum Levels of Analysis(MLA) for orienteering, as specified in the WADA Technical Document for Sport Specific Analysis, are 15% ESAs and 5% Human Growth Hormone (GH) and Growth Hormone Releasing Factors (GHRFs). As of 30 September 2016, these numbers stand at 17.7% ESAs and 8.8% GH/GHRF.

wada

WADA have also released their report on the 2015 Anti-Doping Testing Figures.

In reading the 2015 Report, it is important to note that:

  • One single result does not necessarily correspond to one athlete. Results may correspond to multiple findings regarding the same athlete or measurements performed on the same athlete; such as, in the case of longitudinal studies of testosterone.
  • The number of Adverse Analytical Findings in the Report may not correspond with the number of Anti-Doping Rule Violations reported. This is because all results are subject to a results management process, which includes matching results with Therapeutic Use Exemptions (TUEs), longitudinal studies, which can result in no case to answer or no sanction.

 

|| Print page ||
  • Search the Website

  • IOF Main Sponsor

    IOF Main Sponsor

    Nokian Tyres

  • IOF Sponsors

    IOF Sponsors

    Siven Sport
    BML Print

  • World Championships

  • World Ski Orienteering Championships 2017
    5-13 March 2017

  • Nokian Tyres World Orienteering Championships 2017
    30 June - 8 July 2017

  • World Trail Orienteering Championships 2017
    10-15 July 2017

  • World Mountain Bike Orienteering Championships 2017
    19-27 August 2017

  • Other Upcoming Events

  • World Masters Orienteering Championships 2017
    22-29 April 2017

  • Orienteering World Cup Round 1 2017
    25-28 May 2017

  • European Youth Orienteering Championships 2017
    29 June - 2 July 2017

  • The World Games 2017
    25-27 July 2017

  • World Masters MTB Orienteering Championships 2017
    29 July - 5 August 2017

  • European MTB Orienteering Championships 2017
    29 July - 5 August 2017

  • IOF Partners

  • International Olympic Committee

  • ARISF_logos_05

    Association of IOC Recognised International Sport Federations

  • International World Games Association

  • International Masters Games Association

  • SportAccord

  • World Anti-Doping Agency

  • International University Sports Federation (FISU)

  • Conseil International du Sport Militaire (CISM)

  • European University Sports Association

  • International School Sport Federation